Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides Brett W. AndersonAndrezj P. KudelkaConstantin G. Ioannides ORIGINAL ARTICLE Pages: 459 - 468
Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas Krzysztof WarzochaPatricia RibeiroGilles Salles ORIGINAL ARTICLE Pages: 469 - 475
Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines Michael GranerAmy RaymondEmmanuel Katsanis ORIGINAL ARTICLE Pages: 476 - 484
Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas Bernhard HemmerleinAntje MarkusHeinz-Joachim Radzun ORIGINAL ARTICLE Pages: 485 - 492
Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcγRI and the epidermal growth factor receptor Paul K. WallaceJean-Loup Romet-LemonneCamilo E. Fadul ORIGINAL ARTICLE Pages: 493 - 503
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule Heidi HörigDavid S. LeeHoward L. Kaufman ORIGINAL ARTICLE Pages: 504 - 514